The strong EPS beat and raised organic sales guidance are positive, but the EBITDA guidance cut and $336M fire loss create significant uncertainty. Monitor the Q3 2026 call for updates on insurance recoveries, the pace of operational investments, and whether the Middle East conflict continues to pressure margins. The mixed signals suggest the stock may trade range-bound until the EBITDA trajectory becomes clearer.
Price Chart
Executive Summary
Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of $0.32 by 56%, and revenue of $7.69B, beating $7.51B by 2.3%. Organic sales guidance was raised to 9.0%-10.0% from 8.5%-9.5%, but Adjusted EBITDA guidance was cut to $3.3-$3.4B from $3.5-$3.6B, reflecting inflationary pressure, operational investments, and a $336M fire loss at the Tracy distribution center. The mixed guidance and one-time fire loss temper the strong headline beat.
Key Financial Metrics
Key Facts
- Q2 2026 adjusted EPS of $0.50 beat consensus of $0.32 by 56%.
- Q2 2026 net sales of $7.7B increased 11.6% YoY, beating consensus of $7.51B.
- Organic sales guidance raised to 9.0%-10.0% from 8.5%-9.5%.
- Adjusted EBITDA guidance cut to $3.3-$3.4B from $3.5-$3.6B.
- Net income fell 58.3% to $139M due to a $336M fire loss at the Tracy distribution center.
- Q2 2026 GAAP diluted EPS was $0.07; adjusted diluted EPS was $0.50.
- First six months 2026 free cash flow was $920M, up 37.1% YoY.
- Net leverage stood at 2.9x trailing-twelve-month Adjusted EBITDA.
Financial Impact
EPS beat by $0.18 (56%) vs consensus; revenue beat by ~$180M (2.3%); EBITDA guidance cut by $200-300M at midpoint.
Risk Factors
- Adjusted EBITDA guidance cut by ~$300M at midpoint signals margin compression from inflation and investments.
- $336M fire loss at Tracy distribution center creates operational disruption and insurance recovery uncertainty.
- GAAP net income fell 58.3% YoY, highlighting the gap between adjusted and reported profitability.
- Higher operating expenses and cost of goods sold from tariffs and Middle East conflict may persist.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3339217 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $36.67 $36.30 | ▼ −1.00% | ▼ −0.39% | $35.25 (−3.86%) |
Aug 5, 2026 8w ago | Press Release | $36.67 $36.30 | ▼ −1.00% | ▼ −0.39% | $35.25 (−3.86%) |
Jul 9, 2026 12w ago | 8-K | $41.04 $35.23 | ▼ −14.16% | ▼ −16.58% | $35.25 (−14.11%) |
Jun 11, 2026 16w ago | Institutional Cluster | $37.13 $40.85 | ▲ +10.02% | ▲ +8.13% | $35.25 (−5.06%) |
Jun 2, 2026 17w ago | 8-K | $33.19 $41.73 | ▲ +25.73% | ▲ +27.30% | $35.25 (+6.21%) |
Jun 1, 2026 17w ago | Insider Cluster | $33.19 $41.73 | ▼ −25.73% | ▼ −27.30% | $35.25 (−6.21%) |
Jun 1, 2026 17w ago | Insider Cluster | $33.19 $41.73 | ▼ −25.73% | ▼ −27.30% | $35.25 (−6.21%) |
May 22, 2026 19w ago | EFFECT | $37.01 $35.31 | ▼ −4.59% | ▼ −3.18% | $35.25 (−4.76%) |
May 22, 2026 19w ago | Press Release | $37.01 $35.31 | ▲ +4.59% | ▲ +3.18% | $35.25 (+4.76%) |
May 20, 2026 19w ago | Press Release | $36.25 $35.94 | ▲ +0.86% | ▲ +1.60% | $35.25 (+2.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access